Suppr超能文献

血管紧张素II和缓激肽对离体大鼠肾脏中前列腺素合成及血管张力的作用机制。钙离子拮抗剂和钙调蛋白抑制剂的影响。

Mechanism of action of angiotensin II and bradykinin on prostaglandin synthesis and vascular tone in the isolated rat kidney. Effect of Ca++ antagonists and calmodulin inhibitors.

作者信息

Cooper C L, Shaffer J E, Malik K U

出版信息

Circ Res. 1985 Jan;56(1):97-108. doi: 10.1161/01.res.56.1.97.

Abstract

We have studied the effect of angiotensin II and bradykinin on prostaglandin output and vascular tone during extracellular calcium depletion and administration of calcium antagonists and calmodulin inhibitors to elucidate the mechanism of action in the isolated rat kidney perfused with Tyrode's solution. Administration of angiotensin II (0.028-0.28 nmol) or bradykinin (0.28-2.8 nmol) enhanced the output of prostaglandin E2 and 6-keto-prostaglandin F1 alpha in a dose-dependent manner. Angiotensin II, but not bradykinin, produced renal vasoconstriction. Omission of calcium from the medium or infusion of calcium entry blockers, diltiazem (60 microM), or nimodipine (47 microM), failed to alter prostaglandin output elicited by angiotensin II or bradykinin; however, the effect of angiotensin II to produce renal vasoconstriction was inhibited. If calcium was omitted from the medium, the intracellular calcium antagonists, 8-(diethylamino)octyl 3,4,5-trimethoxybenzoate hydrochloride (23 microM), dantrolene sodium (31 microM), or ryanodine (2 microM), attenuated prostaglandin output caused by angiotensin II but not bradykinin. Calmodulin inhibitors, trifluoperazine (2 microM), napthalene sulfonamide hydrochloride (2 microM), or calmidazolium (2 microM), diminished prostaglandin output elicited by angiotensin II, but not that caused by bradykinin. Trifluoperazine, but not naphthalene sulfonamide or calmidazolium, attenuated the renal vasoconstrictor effect of angiotensin II. Prostaglandin output induced by angiotensin II and bradykinin were inhibited by mepacrine and indomethacin, whereas, the prostaglandin output caused by exogenous arachidonic acid (33 nmol) was abolished by indomethacin but was unaltered by mepacrine, calcium antagonists, and calmodulin inhibitors. From these data, we conclude that angiotensin II produces renal vasoconstriction by a mechanism dependent on extracellular calcium but not calmodulin, whereas angiotensin II-induced prostaglandin output depends on intracellular calcium and calmodulin. In contrast, bradykinin appears to stimulate prostaglandin synthesis by a calcium/calmodulin-independent mechanism.

摘要

我们研究了血管紧张素II和缓激肽在细胞外钙缺失以及给予钙拮抗剂和钙调蛋白抑制剂时对前列腺素生成和血管张力的影响,以阐明在灌注台氏液的离体大鼠肾脏中的作用机制。给予血管紧张素II(0.028 - 0.28 nmol)或缓激肽(0.28 - 2.8 nmol)以剂量依赖方式增强了前列腺素E2和6 - 酮 - 前列腺素F1α的生成。血管紧张素II而非缓激肽引起肾血管收缩。从培养基中去除钙或输注钙通道阻滞剂地尔硫卓(60 μM)或尼莫地平(47 μM),未能改变血管紧张素II或缓激肽引起的前列腺素生成;然而,血管紧张素II引起肾血管收缩的作用受到抑制。如果从培养基中去除钙,细胞内钙拮抗剂盐酸8 - (二乙氨基)辛基3,4,5 - 三甲氧基苯甲酸酯(23 μM)、丹曲林钠(31 μM)或ryanodine(2 μM)会减弱血管紧张素II而非缓激肽引起的前列腺素生成。钙调蛋白抑制剂三氟拉嗪(2 μM)、盐酸萘磺酰胺(2 μM)或氯米达唑(2 μM)会减少血管紧张素II引起的前列腺素生成,但不会减少缓激肽引起的前列腺素生成。三氟拉嗪而非萘磺酰胺或氯米达唑减弱了血管紧张素II的肾血管收缩作用。血管紧张素II和缓激肽诱导的前列腺素生成受到米帕林和吲哚美辛的抑制,而外源性花生四烯酸(33 nmol)引起的前列腺素生成被吲哚美辛消除,但不受米帕林、钙拮抗剂和钙调蛋白抑制剂的影响。从这些数据中,我们得出结论,血管紧张素II通过一种依赖细胞外钙而非钙调蛋白的机制引起肾血管收缩,而血管紧张素II诱导的前列腺素生成依赖细胞内钙和钙调蛋白。相比之下,缓激肽似乎通过一种不依赖钙/钙调蛋白的机制刺激前列腺素合成。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验